IP Library › Granted Patent US 8,513,217
Granted Patent B2
US 8,513,217 · App. 12/882,624 · Granted Aug 20, 2013

Biopolymer system for tissue sealing

Inventors: Weiliam Chen (Mount Sinai, NY); John M. Abrahams (Scarsdale, NY)
Assignee: Endomedix, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,513,217
App. No.
12/882,624
Granted
Aug 20, 2013
Kind
B2
Abstract

A tissue sealant for use in surgical and medical procedures for sealing the tissues of a living mammal is provided. The tissue sealant comprises a hydrogel which is formed by gelation of a premix disposed on the tissue to be sealed. The premix comprises alkylated chitosan or a gelatin, and a polybasic carboxylic acid or an oxidized polysaccharide, in an aqueous medium. The premix can also include a dehydrating reagent, a carboxyl activating reagent, or both. A specific use of the tissue sealant is in the repair of the dura mater after brain surgery to prevent leakage of cerebrospinal fluid. The tissue sealant may include a therapeutic or protective agent such as an antibiotic or an anti-inflammatory drug.

Claims (22)

1. A method of sealing a disrupted biological tissue in need thereof in a living mammal, the method comprising applying to the disrupted biological tissue a biocompatible, biodegradable composition produced by mixing a first solution comprising an acrylated chitosan with a second solution comprising oxidized dextran to produce a mixture comprising from about 1% to about 10% by weight of the acrylated chitosan, wherein the acrylated chitosan has a degree of substitution of a chitosan backbone with acrylate groups in the range of from about 0.25 to about 0.5,

such that, when the mixture is applied to the disrupted biological tissue, the mixture forms a hydrogel within a minute after mixing thereby sealing the biological tissue.

2. The method of claim 1 wherein the biological tissue comprises a meninx of a nervous system organ.

3. The method of claim 2 wherein the nervous system organ comprises brain or spinal cord.

4. The method of claim 1 wherein sealing comprises adhesively sealing.

5. The method of claim 1 wherein the biological tissue comprises blood vessels or musculature.

6. The method of claim 1 wherein the biological tissue comprises the annulus of an intervertebral disk.

7. The method of claim 1 wherein the biological tissue comprises cartilage or bone.

8. The method of claim 1 wherein the biological tissue comprises neural tissue or dermal tissue.

9. The method of claim 8 comprising sealing any laceration, cut, abrasion, or disruption of the dermal tissue.

10. The method of claim 1 comprising adhesively sealing the disrupted biological tissue against leakage of a biological fluid.

11. The method of claim 10 wherein the biological fluid is cerebrospinal fluid.

12. The method of claim 1 comprising reinforcement of a sutured biological tissue.

13. The method of claim 1 comprising holding portions of disrupted biological tissue in mutual proximity.

14. The method of claim 1 comprising filling in a void resulting from tissue removal.

15. The method of claim 1 , wherein the composition further comprises a dye material or a radio-opaque material.

16. The method of claim 1 , wherein the composition further comprises a therapeutic or protective agent.

17. The method of claim 1 , wherein the acrylated chitosan concentration is about 3% to about 7% by weight.

18. The method of claim 1 , wherein the mixture comprises about 5% by weight of the acrylated chitosan.

19. The method of claim 1 , wherein the first solution comprises from about 1% to about 10% acrylated chitosan.

20. The method of claim 1 , wherein the degree of substitution of the acrylated chitosan is in the range from about 0.25 to about 0.45.

21. The method of claim 1 , wherein the degree of substitution of the acrylated chitosan is about 0.5.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2010
From: CHEN, WEILIAM; ABRAHAMS, JOHN M.
To: ENDOMEDIX, INC.
Reel/Frame 025086/0721 →
Continuity (3)
Division 11530362 · Sep 8, 2006
Continuation In Part 11379182 · Apr 18, 2006
Related Publication 20110002999A1 · Jan 6, 2011